03:13:27 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



Ventripoint Diagnostics Ltd (2)
Symbol VPT
Shares Issued 137,678,405
Close 2021-09-17 C$ 0.52
Market Cap C$ 71,592,771
Recent Sedar Documents

Ventripoint grants option for 300,000 shares

2021-09-17 16:40 ET - News Release

Mr. Peter Weichler reports

VENTRIPOINT ISSUES OPTION GRANTS TO CONSULTANT

On Sept. 15, 2021, Ventripoint Diagnostics Ltd.'s board of directors approved the granting of an aggregate of 300,000 options to a consultant of the corporation at exercise prices from 50 cents to 55 cents for a term of one year and vesting from immediately to over nine months. The corporation now has 6,006,590 options available for future grants under the stock option plan as approved by shareholders at the last special and annual general meeting on Aug. 9, 2021.

About Ventripoint Diagnostics Ltd.

Ventripoint has become an industry leader in the application of AI (artificial intelligence) to echocardiography. Ventripoint's VMS products are powered by its proprietary KBR technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI. This affordable, gold-standard alternative allows cardiologists greater confidence in the management of their patients. Providing better care to patients serves as a springboard and basic standard for all of Ventripoint's products that guide our future developments. In addition, VMS+ is versatile and can be used with all ultrasound systems from any vendor supported by regulatory market approvals in the United States, Europe and Canada.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.